drugset / Trial / NCT01949818
Treatment of Diffuse Large B Cell Lymphoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Yangzhengxiaoji Capsule Combination Chemotherapy for III/IV Diffuse Large B Cell Lymphoma.
Timeline
- Start
- 2012-09
- Primary completion
- 2016-09
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yangzhengxiaoji capsule | Unknown | 1.56 g | Oral |
| Background | Cyclophosphamide | Other / unclassified | 750 mg | Intravenous |
| Background | Doxorubicin | Other / unclassified | 50 mg/m2 | Intravenous |
| Background | Prednisone | Other / unclassified | 60 mg/m2 | Oral |
| Background | Vincristine | Small molecule | 1.4 g | Intravenous |